Congrats to all our presenters at #ACG2025! Especially proud of our chief fellow, @BSchwartzMD on his excellent presentation and ACG governor’s award for excellence in clinical research, in addition to our outstanding and presidential poster award winners! 🤩
@AmCollegeGastro
⚕️We have an excellent agenda & an all-star lineup of experts for the #RushIntoGI conference in February! Take a peek 👉 https://t.co/pi3uKX78pE
🔹Register 👉 https://t.co/BVEXUuVX2G
#livertwitter#GItwitter#Chicago#GHAPP@RushDOIM
Do you incorporate telemedicine in your Hepatology practice? Telemedicine is susceptible to creating 'intervention-generated inequalities'. Read more on how to combat these liver health disparities:
https://t.co/mGwXV70OPx
@CLD_Learning#CLDSoMeReps@Julius__Wilder@NancyReau
Breaking down Hepatic Encephalopathy for patients and families can be a challenge. This is a great resource for them to better understand HE.
https://t.co/jqtxyzm7Xo
@CLD_Learning#CLDSoMeReps@Julius__Wilder@NancyReau
Do you recommend bariatric surgery for treatment of NASH fibrosis? A great overview of the current evidence supporting utilizing bariatric surgery as a key intervention in the fight against NASH
https://t.co/DuMgjLR7fN
@CLD_Learning#CLDSoMeReps@Julius__Wilder@NancyReau
How should we approach end-of-life discussions with patients with advanced liver disease while maintaining cultural humility? A great article summarizing some initial approaches:
https://t.co/h3c7Zo1uzS
@CLD_Learning#CLDSoMeReps#CLDREP@Julius__Wilder@NancyReau
Had an incredible time meeting experts from across the globe and presenting my work on AIH/NAFLD overlap and PEG tube complications at #DDW2022 with the Rush GI crew. Excited for next year in Chicago!
@NancyReau@DDWMeeting@RushMedical@RushIMChiefs
So much fun at my first DDW! Grateful for the opportunity to share my research and learn from leaders in the field. Looking forward to next year already! @DDWMeeting@AmerGastroAssn@RushMedical@RushDOIM
Great article covering the multifactorial pathophysiology of HE: neuro-inflammation, alterted neurotransmission, bile acids, the microbiome, and nutrition all contribute in addition to ammonia
https://t.co/5EKg70uraP
@CLD_Learning#CLDSoMeReps@Julius__Wilder@NancyReau
Statins may slow liver disease progression and HCC. Here's a great overview of the preclinical/retrospective data. Ongoing clinical trials may give us more answers and help guide future treatment
https://t.co/fZRtPYhz1V
@CLD_Learning#CLDSoMeReps@Julius__Wilder@NancyReau
Great review article covering socioeconomic disparities of travel for liver transplantation. Have we adequately evaluated the ethical considerations?
https://t.co/fh0mx5NT7E
@CLD_Learning#CLDSoMeReps#CLDREP@Julius__Wilder@NancyReau